A funding program for new anti-cancer drugs in Ontario, Canada, based on quality of evidence and a hierarchy of outcomes

被引：0
|
作者：
Evans, WK
Pater, J
Nefsky, N
Brouwers, M
Browman, G
Cowan, D
机构：
[1] Canc Care Ontario, Toronto, ON, Canada
[2] Queens Univ, Natl Canc Inst Canada Clin Trials, Kingston, ON, Canada
[3] McMaster Univ, Program Evidence Based Care, Hamilton, ON, Canada
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：300 / 301
页数：2
相关论文
共 50 条
  • [21] Glycoprotein glycosylation: Targets for new anti-cancer drugs.
    Dennis, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 38 - CARB
  • [22] Novel ceramide analogs are new anti-cancer drugs.
    Bieberich, E
    Hu, B
    Silva, J
    MacKinnon, S
    Yu, RK
    Ottenbrite, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U432 - U432
  • [23] Cardiac toxicity:: old and new issues in anti-cancer drugs
    Sereno, Maria
    Brunello, Antonella
    Chiappori, Alberto
    Barriuso, Jorge
    Casado, Enrique
    Belda, Cristobal
    de Castro, Javier
    Feliu, Jaime
    Gonzalez-Baron, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (01): : 35 - 46
  • [24] Cardiac toxicity: old and new issues in anti-cancer drugs
    María Sereno
    Antonella Brunello
    Alberto Chiappori
    Jorge Barriuso
    Enrique Casado
    Cristóbal Belda
    Javier de Castro
    Jaime Feliu
    Manuel González-Barón
    Clinical and Translational Oncology, 2008, 10 : 35 - 46
  • [25] Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
    Bertoni, Francesco
    Rapposelli, Simona
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Funding new cancer drugs in Ontario: Closing the loop in the practice guidelines development cycle
    Pater, JL
    Browman, GP
    Brouwers, MC
    Nefsky, MF
    Evans, WK
    Cowan, DH
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) : 3392 - 3396
  • [27] Translation of evidence into funding policy: An overview of guidelines from the Cancer Care Ontario's Program in Evidence-Based Care (PEBC).
    Ramjeesingh, R.
    Meyer, R. M.
    Brouwers, M. C.
    Booth, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs
    Khan, Tabassum
    Gurav, Pranav
    FRONTIERS IN PHARMACOLOGY, 2018, 8
  • [29] The impact of the Ontario quality-based procedures funding model on radical prostatectomy outcomes
    Motamedi, Nickan
    McClure, Andrew
    Power, Nicholas E.
    Pautler, Stephen
    Given, Lilian
    Welk, Blayne
    McGee, Jacob
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (09): : E269 - E275
  • [30] Clinical evidence and benefit of special FDA designations in anti-cancer drugs.
    Michaeli, Daniel Tobias
    Michaeli, Julia Caroline
    Albers, Sebastian
    Boch, Tobias
    Winterhoff, Boris
    Michaeli, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345